A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study
Conditions: Oesophageal Cancer Interventions: Drug: Durvalumab Sponsors: Australasian Gastro-Intestinal Trials Group Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Esophagus Cancer | Gastroenterology | Palliative | Research | Study